- •The first prospective surgical study in elderly women with gynecologic cancers
- •Treatment patterns of elderly women with gynecologic malignancies
- •Geriatric assessment scores correlate with post-operative complications
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- Cancer in the elderly.Trans. Am. Clin. Climatol. Assoc. 2006; 117: 147-156
- SEER Cancer Statistics Review, 1975-2008.National Cancer Institute, Bethesda, MD2011based on November 2010 SEER data submission, posted to the SEER web site)
- National survey of ovarian carcinoma: patterns of care and related survival for older patients.Cancer. 1994; 73: 377-383
- Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy.Gynecol. Oncol. 2007; 106: 381-387
- Effect of radical cytoreductive surgery on omission and delay of chemotherapy for advanced stage ovarian cancer.Obstet. Gynecol. 2012; 120: 871-881
- Variability in chemotherapy delivery for elderly women with advanced stage ovarian cancer and its impact on survival.Br. J. Cancer. 2008; 98: 1197-1203
- Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.N. Engl. J. Med. 2010; 363: 943-953
- An analysis of patients with bulky advanced stage ovarian, tubal and peritoneal carcinoma treated with primary debulking surgery during an identical time period as the randomized EORTC-NCIC trial of PDS vs. neoadjuvant chemotherapy.Gynecol. Oncol. 2012; 124: 10-14
- “Surgical Apgar score” predicts postoperative complications after cytoreduction for advanced ovarian cancer.Gynecol. Oncol. 2010; 116: 370-373
- Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.Gynecol. Oncol. 2011; 120: 23-28
- Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.Am. J. Obstet. Gynecol. 2007; 197 (676.e1–7)
- Implementing a geriatric assessment in cooperative group clinical Cancer trials: CALGB 360401.J. Clin. Oncol. 2011; 29: 1290-1296
- Predicting chemotherapy toxicity in older adults with Cancer: a prospective multicenter study.J. Clin. Oncol. 2011; 29: 3457-3465
- Developing a Cancer specific geriatric assessment.Cancer. 2005; 104: 1998-2005
- Preoperative assessment of Cancer in elderly patients: a pilot study.Support Cancer Ther. 2003; 1: 55-60
- Shall we operate? Preoperative assessment in elderly patients can help.Crit. Rev. Oncol. Hematol. 2008; 65: 156-163
☆This study was supported by National Cancer Institute grants to NRG Oncology ( 1 U10 CA180822 ), NRG Operations ( U10CA180868 ) and NCORP ( UG1CA189867 ). The following Gynecologic Oncology institutions participated in this study: University of Iowa/Holden Comprehensive Cancer Center; University of Oklahoma Health Sciences Center, University of Pennsylvania/Abramson Cancer Center, Abington Memorial Hospital, Maine Medical Center-Scarborough Campus, Memorial Sloan Kettering Cancer Center, University of Virginia Cancer Center, Duke University Medical Center, Dartmouth-Hitchcock Medical Center/Norris Cotton Cancer Center, Women's Cancer Center of Ne3vada, Hartford Hospital, University of Alabama at Birmingham Cancer Center, Froedtert and the Medical College of Wisconsin, Washington University School of Medicine, UT Southwestern/Simmons Cancer Center-Dallas, Rush University Medical Center, Mayo Clinic, Women and Infants Hospital, Avera Cancer Institute, Parkview Hospital Randallia, Wayne State University/Karmanos Cancer Institute, Henry Ford Hospital, Saint Joseph's Hospital and Medical Center, UCLA/Jonsson Comprehensive Cancer Center, and UC San Diego Moores Cancer Center.